| |
| |
|
| Insider
Information: |
Stephenson Pamela |
| Relationship: |
|
| City: |
Devon |
| State: |
PA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
36,666 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,128,213 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
36,666 |
|
|
| Total
Value |
$1,128,213 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 224.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Albireo Pharma Inc |
ALBO |
Chief Commercial Officer |
2023-03-02 |
0 |
2019-03-25 |
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
|
2023-10-10 |
0 |
2021-08-03 |
0 |
Premium* |
|
|
Disc Medicine, Inc |
IRON |
|
2024-02-26 |
36,666 |
2024-02-26 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IRON |
Disc Medicine, Inc |
Chief Commercial Officer |
• – – |
2024-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
36,666 |
36,666 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
|
• • – |
2023-10-10 |
4 |
D |
$0.00 |
$0 |
D/D |
(75,778) |
0 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-14 |
4 |
S |
$0.35 |
$40 |
D/D |
(115) |
75,778 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2023-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
47,824 |
75,893 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2023-03-02 |
4 |
D |
$0.00 |
$0 |
D/D |
(22,242) |
0 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2023-01-23 |
4 |
AS |
$43.80 |
$4,468 |
D/D |
(102) |
42,755 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2023-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
55,000 |
97,755 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2023-01-19 |
4 |
AS |
$43.90 |
$77,886 |
D/D |
(1,774) |
42,857 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-12-27 |
4/A |
AS |
$19.06 |
$8,940 |
D/D |
(469) |
44,631 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-12-27 |
4 |
AS |
$19.06 |
$8,940 |
D/D |
(469) |
45,178 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-10-24 |
4 |
AS |
$19.58 |
$2,036 |
D/D |
(104) |
45,647 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-09-26 |
4 |
AS |
$19.40 |
$8,635 |
D/D |
(445) |
45,751 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-07-22 |
4 |
AS |
$24.67 |
$2,615 |
D/D |
(106) |
46,196 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-07-22 |
4/A |
AS |
$24.67 |
$2,615 |
D/D |
(106) |
45,649 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-06-27 |
4 |
AS |
$19.47 |
$8,976 |
D/D |
(461) |
45,755 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
S |
$1.01 |
$40 |
D/D |
(40) |
28,069 |
0 |
% |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2022-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
23,109 |
28,109 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-04-22 |
4 |
AS |
$32.92 |
$3,391 |
D/D |
(103) |
46,216 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-03-28 |
4 |
AS |
$30.53 |
$13,858 |
D/D |
(454) |
46,319 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-01-24 |
4 |
AS |
$24.88 |
$10,351 |
D/D |
(416) |
46,773 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2022-01-18 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
47,189 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2021-12-27 |
4 |
AS |
$23.92 |
$11,339 |
D/D |
(474) |
25,589 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2021-09-27 |
4 |
AS |
$32.05 |
$14,456 |
D/D |
(451) |
26,063 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
Director |
– • – |
2021-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ALBO |
Albireo Pharma Inc |
Chief Commercial Officer |
• – – |
2021-06-25 |
4 |
AS |
$36.01 |
$16,961 |
D/D |
(471) |
26,514 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
